LAMB2 and breast carcinoma: Results obtained using the other cell lines (e.g., breast carcinoma MDA-MB-231 and lung carcinoma A549; representing other carcinoma types) illustrate the generality of our findings, applicable to cells that either do (A431) or do not (MDA-MB-231, A549) produce excess laminin.